BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30654236)

  • 1. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
    Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
    Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
    Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
    Kang S; Kim RY; Seo MJ; Lee S; Kim YM; Seo M; Seo JJ; Ko Y; Choi I; Jang J; Nam J; Park S; Kang H; Kim HJ; Kim J; Ahn S; Pethe K; Nam K; No Z; Kim J
    J Med Chem; 2014 Jun; 57(12):5293-305. PubMed ID: 24870926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203.
    Kang S; Kim YM; Kim RY; Seo MJ; No Z; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Jan; 125():807-815. PubMed ID: 27750198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
    Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
    Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
    Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
    Wang A; Ma C; Chai Y; Liu X; Lv K; Fu L; Wang B; Jia X; Liu M; Lu Y
    Eur J Med Chem; 2020 Aug; 200():112409. PubMed ID: 32460114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Wu Z; Lu Y; Li L; Zhao R; Wang B; Lv K; Liu M; You X
    ACS Med Chem Lett; 2016 Dec; 7(12):1130-1133. PubMed ID: 27994751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
    Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
    ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
    Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
    Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.